PRKDC and cancer: KU-0060648 exhibits differential growth inhibitory effects but not profoundly cytotoxic in multiple human cancer cell lines, and it works as a dual DNA-PK (IC50 = 8.6 nM) and PI3Ks inhibitor (IC50 = 0.59 μM for PI3Kγ) [27].